z-logo
Premium
Increasing the evidence for surveillance of metastatic renal cancer
Author(s) -
Bex Axel
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33490
Subject(s) - medicine , cancer , kidney cancer , intensive care medicine , oncology
Patients with low‐volume metastatic renal cell carcinoma, good performance, and few risk factors can be managed with a period of active surveillance. This period can vary between months and years.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom